$0.6578
-0.00220-0.33%
At close: -
$0.6525
-0.00530-0.81%
After Hours: May 16, 7:27 PM EDT
Comments
Loading...
Adial Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:ADIL | Benzinga
Adial Pharmaceuticals Inc has a consensus price target of $7 based on the ratings of 3 analysts. The high is $8 issued by Rodman & Renshaw on November 14, 2024. The low is $6 issued by Brookline Capital on July 11, 2023. The 2 most-recent analyst ratings were released by Rodman & Renshaw and Brookline Capital on November 14, 2024 and July 11, 2023, respectively. With an average price target of $7 between Rodman & Renshaw and Brookline Capital, there's an implied 972.80% upside for Adial Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Rodman & Renshaw
Brookline Capital
1calculated from analyst ratings
Analyst Ratings for Adial Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/14/2024 | Buy Now | 1126.05% | Rodman & Renshaw | Brandon Folkes38% | → $8 | Initiates | → Buy | Get Alert |
| 07/11/2023 | Buy Now | 819.54% | Brookline Capital | Kumaraguru Raja19% | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/17/2022 | Buy Now | — | Maxim Group | Jason McCarthy42% | — | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Adial Pharmaceuticals (ADIL) stock?
The latest price target for Adial Pharmaceuticals (NASDAQ:ADIL) was reported by Rodman & Renshaw on November 14, 2024. The analyst firm set a price target for $8.00 expecting ADIL to rise to within 12 months (a possible 1126.05% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Adial Pharmaceuticals (ADIL)?
The latest analyst rating for Adial Pharmaceuticals (NASDAQ:ADIL) was provided by Rodman & Renshaw, and Adial Pharmaceuticals initiated their buy rating.
When was the last upgrade for Adial Pharmaceuticals (ADIL)?
There is no last upgrade for Adial Pharmaceuticals
When was the last downgrade for Adial Pharmaceuticals (ADIL)?
The last downgrade for Adial Pharmaceuticals Inc happened on August 17, 2022 when Maxim Group changed their price target from N/A to N/A for Adial Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Adial Pharmaceuticals (ADIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Adial Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Adial Pharmaceuticals was filed on November 14, 2024 so you should expect the next rating to be made available sometime around November 14, 2025.
Is the Analyst Rating Adial Pharmaceuticals (ADIL) correct?
While ratings are subjective and will change, the latest Adial Pharmaceuticals (ADIL) rating was a initiated with a price target of $0.00 to $8.00. The current price Adial Pharmaceuticals (ADIL) is trading at is $0.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
